Ascendis Pharma (NasdaqGS:ASND) FDA announcement Transcript

Ascendis Pharma (NasdaqGS:ASND) FDA announcement March 02, 2026 08:00 AM ET Company ParticipantsAimee Shu - EVP and Chief Medical OfficerAlex Thompson - Managing DirectorChad Fugere - VP of Investor RelationsGavin Clark-Gartner - Director of Biotechnology Equity ResearchHeidi Jacobson - Equity Research AssociateJan Mikkelsen - President and CEOJay Wu - EVPMaxwell Schorr - Senior VPSimone Nasroodin - Biotech Equity Research AssociateTazeen Ahmad - Managing DirectorYaron Werber - Managing DirectorYun Zhong - ...